Atlas Trials

Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer

Clinical trial NCT06918262 · RECRUITING

Trial details

NCT number
NCT06918262
Sponsor
The First Hospital of Jilin University
Status
RECRUITING
Study type
OBSERVATIONAL
Breast CancerMRD
Start date
2024-01-01
Primary completion
2027-01-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.